Long-term follow-up of HLA-A2+ patients with high-risk, hormone-sensitive prostate cancer vaccinated with the prostate specific antigen peptide homologue (PSA146-154).
about
Long-term follow-up of HLA-A2+ patients with high-risk, hormone-sensitive prostate cancer vaccinated with the prostate specific antigen peptide homologue (PSA146-154).
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@ast
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@en
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@nl
type
label
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@ast
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@en
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@nl
prefLabel
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@ast
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@en
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@nl
P2093
P2860
P356
P1476
Long-term follow-up of HLA-A2+ ...... eptide homologue (PSA146-154).
@en
P2093
David J Peace
Seby Edassery
Supriya Perambakam
P2860
P304
P356
10.1155/2010/473453
P577
2010-01-01T00:00:00Z